Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
Clinical Characteristics and Outcomes of Anemia in Critically Ill Patients: A Cross-Sectional Observational Study from a Tertiary Intensive Care Unit in Nepal.
Journal: Kathmandu University medical journal (KUMJ)
Published: April 24, 2026
Belantamab Mafodotin for Patients With Multiple Myeloma: Clinical Development and Practical Strategies for Dose Optimization and Toxicity Management.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 07, 2026
Older and frail patients with multiple myeloma treated with bispecific antibodies: A systematic review and meta-analysis.
Journal: British journal of haematology
Published: February 10, 2026
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 14, 2026
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 14, 2026
Implementation of Bispecific Antibodies in the Community: Lessons From the ThedaCare Cancer Center Experience.
Journal: JCO oncology practice
Published: January 13, 2026
Changes in patient-reported distress and symptom burden during talquetamab therapy in multiple myeloma.
Journal: British journal of haematology
Published: December 10, 2025
FREEDOMM: Fifth-Line or Later Real-World Evaluation of Efficacy and Disease Outcomes in Multiple Myeloma with Ciltacabtagene Autoleucel: Treatment-Free Interval and Overall Survival in the USA.
Journal: Advances in therapy
Published: December 09, 2025
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.
Journal: Blood cancer journal
Published: December 04, 2025
Redefining functional high-risk multiple myeloma in the context of upfront quadruplet therapy and autologous stem cell transplantation.
Journal: Cancer
Published: November 22, 2025
Last Updated: 09/26/2026